Literature DB >> 23288509

ALX1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of ovarian cancer cells.

Hong Yuan1, Hiroaki Kajiyama, Satoko Ito, Nobuhisa Yoshikawa, Toshinori Hyodo, Eri Asano, Hitoki Hasegawa, Masao Maeda, Kiyosumi Shibata, Michinari Hamaguchi, Fumitaka Kikkawa, Takeshi Senga.   

Abstract

Ovarian cancer is a highly invasive and metastatic disease with a poor prognosis if diagnosed at an advanced stage, which is often the case. Recent studies argue that ovarian cancer cells that have undergone epithelial-to-mesenchymal transition (EMT) acquire aggressive malignant properties, but the relevant molecular mechanisms in this setting are not well-understood. Here, we report findings from an siRNA screen that identified the homeobox transcription factor ALX1 as a novel regulator of EMT. RNA interference-mediated attenuation of ALX1 expression restored E-cadherin expression and cell-cell junction formation in ovarian cancer cells, suppressing cell invasion, anchorage-independent growth, and tumor formation. Conversely, enforced expression of ALX1 in ovarian cancer cells or nontumorigenic epithelial cells induced EMT. We found that ALX1 upregulated expression of the key EMT regulator Snail (SNAI1) and that it mediated EMT activation and cell invasion by ALX1. Our results define the ALX1/Snail axis as a novel EMT pathway that mediates cancer invasion. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23288509     DOI: 10.1158/0008-5472.CAN-12-2377

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  microRNA-31 modulates skeletal patterning in the sea urchin embryo.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

2.  Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

3.  The SNAI1 3'UTR functions as a sponge for multiple migration-/invasion-related microRNAs.

Authors:  Jun Li; Hailin Yu; Meili Xi; Duan Ma; Xin Lu
Journal:  Tumour Biol       Date:  2014-10-19

4.  Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition.

Authors:  Lindsay R Saunders; David R McClay
Journal:  Development       Date:  2014-03-05       Impact factor: 6.868

5.  ALX1 promotes migration and invasion of lung cancer cells through increasing snail expression.

Authors:  Wei Yao; Yong Liu; Zhuo Zhang; Guoquan Li; Xiaoying Xu; Kun Zou; Yinghui Xu; Lijuan Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  A small sustained increase in NOD1 abundance promotes ligand-independent inflammatory and oncogene transcriptional responses.

Authors:  Leah M Rommereim; Ajay Suresh Akhade; Bhaskar Dutta; Carolyn Hutcheon; Nicolas W Lounsbury; Clifford C Rostomily; Ram Savan; Iain D C Fraser; Ronald N Germain; Naeha Subramanian
Journal:  Sci Signal       Date:  2020-12-08       Impact factor: 8.192

7.  Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma.

Authors:  Mingfu Yang; Yong Pan; Yue Zhou
Journal:  Tumour Biol       Date:  2015-03-04

8.  GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.

Authors:  Jianquan Zhao; Chun Yang; Shujun Guo; Yonggang Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

10.  Novel Potential Biomarkers for Opisthorchis viverrini Infection and Associated Cholangiocarcinoma.

Authors:  Nithikoon Aksorn; Sittiruk Roytrakul; Suthathip Kittisenachai; Kawin Leelawat; Pithi Chanvorachote; Supachai Topanurak; Shinjiro Hamano; Usa Lek-Uthai
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.